Some drugs require prior authorization before they can be delivered or administered in a health care provider's office, clinic, outpatient or home setting. This page offers resources for providers who request prior authorization for provider-administered (infusible/injectable) drugs billed under the medical benefit for Blue Cross commercial and Medicare Plus BlueSM members.
The process of requesting prior authorization for medical benefit drugs differs according to the member's coverage and the type of drug:
- For Blue Cross commercial members:
- For most medical benefit drugs, submit prior authorization requests through the NovoLogix® web tool. This includes requests for gene and cellular therapy drugs, such as CAR-T.
Note: For Blue Cross and Blue Shield Federal Employee Program® non-Medicare members, you can submit requests through NovoLogix or by fax. For information about faxing prior authorization requests, call the Pharmacy Clinical Help Desk at 1-800-437-3803.
- For medical oncology and supportive care drugs:
- For Blue Cross commercial UAW Retiree Medical Benefits Trust members, submit prior authorization requests to Carelon Medical Benefits Management for all dates of service.
- For other Blue Cross commercial members:
- Carelon Medical Benefits Management reviews prior authorization requests through Dec. 31, 2024. To determine which groups have opted in and the date on which they opted in, see the Carelon medical oncology prior authorization program opt-in list for Blue Cross commercial self-funded groups (PDF).
- Starting Jan. 1, 2025, submit prior authorization requests to OncoHealth. To determine which self-funded groups have requirements under the program, see the Oncology Value Management program participation list for commercial self-funded groups (PDF).
Note: Medical oncology and supportive care drugs don't require authorization through Carelon or OncoHealth for members covered through the Blue Cross and Blue Shield Federal Employee Program®.
- For most medical benefit drugs, submit prior authorization requests through the NovoLogix® web tool. This includes requests for gene and cellular therapy drugs, such as CAR-T.
- For Medicare Plus Blue members:
- For most medical benefit drugs, submit prior authorization requests through NovoLogix. This includes requests for gene and cellular therapy drugs, such as CAR-T.
- For medical oncology and supportive care drugs:
- Carelon reviews prior authorization requests through Dec. 31, 2024.
- Starting Jan. 1, 2025, submit prior authorization requests to OncoHealth.
Did you know? Michigan's prior authorization law* requires health care providers to submit prior authorization requests electronically for commercial members. Alternate submission methods are allowed in the case of temporary technological problems, such as power or internet outages; see the information about submitting prior authorization requests through alternate methods below. When you submit your medical drug prior authorization requests electronically, there are many benefits:
Below, you'll find information on how to submit a medical drug prior authorization request electronically for Blue Cross commercial and Medicare Plus Blue members. You'll also find other helpful resources. |
IMPORTANT! Always verify eligibility and benefits for each member at each visit. A prior authorization approval is not a guarantee of payment.
Blue Cross commercial For Blue Cross commercial members, select from below: How to submit requests electronically using NovoLogix
How to submit requests electronically to Carelon For Blue Cross commercial URMBT members, submit prior authorization requests to Carelon Medical Benefits Management for all dates of service. For other Blue Cross commercial members who have requirements under the Oncology Value Management program, submit requests for medical oncology and supportive care drugs to Carelon for dates of service before Jan. 1, 2025, as follows.
For additional information, refer to the Oncology Value Management program through Carelon FAQs for providers (PDF) How to submit requests electronically to OncoHealth For dates of service on or after Jan. 1, 2025, submit requests for medical oncology and supportive care drugs to OncoHealth. You’ll be able to submit requests to OncoHealth starting Jan. 1, 2025. See the following for additional information:
Note: When prescribing drugs that are on this list for non-oncology diagnoses, don’t submit the prior authorization request to OncoHealth. Instead, fax all clinical documentation to the Pharmacy Clinical Help Desk at 1-877-325-5979. Other resources Newsletter articles (PDF) Lemtrada and Tysabri site-of-care program: FAQ (PDF) In-network home infusion therapy providers and ambulatory infusion centers (PDF) Audaire Health™: |
Medicare Plus Blue Select specialty medications covered under the Medicare Part B medical benefit require prior authorization for members covered under Blue Cross Medicare Advantage plans, including Medicare Plus Blue. For Medicare Plus Blue members, select from below: How to submit requests electronically using NovoLogix
How to submit requests electronically to Carelon For dates of service before Jan. 1, 2025, submit requests for medical oncology and supportive care drugs to Carelon as follows.
For additional information, refer to the Oncology Value Management program through Carelon: FAQs for providers (PDF). How to submit requests electronically to OncoHealth For dates of service on or after Jan. 1, 2025, submit requests for medical oncology and supportive care drugs to OncoHealth. You’ll be able to submit requests to OncoHealth starting Jan. 1, 2025. See the following for additional information:
Note: When prescribing drugs that are on this list for non-oncology diagnoses, don’t submit the prior authorization request to OncoHealth. Instead, fax all clinical documentation to the Pharmacy Clinical Help Desk at 1-877-325-5979. Other resources Medicare Plus Blue medical drug policies and forms webpage Authorization of Part B specialty medications: Frequently asked questions for providers |
RC Claim Assist tool
RC Claim Assist is a web-based resource available to Blue Cross Blue Shield of Michigan and Blue Care Network contracted providers who bill for drugs covered under the medical benefit. RC Claim Assist provides an inclusive overview of medical drug products and a calculation tool to identify the correct National Drug Code and CPT codes to bill, along with the correct NDC quantity, unit of measure and HCPCS billable units according to the package information.
See Using the RC Claim Assist tool: Frequently asked questions for providers (PDF) for additional information.
Training resources
To help you learn to use the NovoLogix web tool:
- NovoLogix training video on requesting prior authorizations:
- Click to open the video*.
- Click the arrow located in the center of the "Provider Authorization Video Tutorial" box, to start the video.
- NovoLogix user guide for Blue Cross providers (PDF)
- Billing instructions: Reporting the NDC (PDF)
- Web-based training about NDC billing:
We offer provider training. To learn more, see our Training Tools page.
Additional resources
- Inquiries about drugs covered under the medical benefit: Frequently asked questions for providers (PDF)
- Billing instructions: Using modifiers JW and JZ (PDF)
- Drugs: For medication adherence, medical benefit drugs and pharmacy benefit drugs (PDF) - Includes information about our care management and utilization management programs
- Oncology: For CAR-T cell therapy, medical oncology and radiation oncology (PDF) - Includes information about our utilization management programs
Alternate methods for submitting prior authorization requests
If you’re experiencing temporary technological problems that prevent you from submitting requests electronically, see the Alternate methods for submitting prior authorization requests for medical benefit drugs (PDF).
Need additional assistance?
For additional help, call the Pharmacy Clinical Help Desk at 1-800-437-3803.
*Clicking this link means that you're leaving the Blue Cross Blue Shield of Michigan and Blue Care Network website. While we recommend this site, we're not responsible for its content.